LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the company is now listed on the Standard & Poors (S&P) SmallCap 600 Index. The addition to the index is based on various criteria, including at least four consecutive quarters of positive as-reported earnings. 2007 was the first full year of GAAP profitability for Cubist, which has now reported six consecutive quarters of GAAP profitable performance.
